Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Nine 'Safer Than AT&T' Stocks Pay The Plumpest, Lead-Free Dividends

AT&T's plump dividend used to be like money in the bank. But now investors seeking income and safety might look elsewhere.

Investors Business Daily

Cheaper TB drugs for millions after global deal on patent rights agreed

Johnson & Johnson allows generic bedaquiline in 44 countries – but concerns remain about ‘stopgap’ solution

The Guardian - UK

Johnson and Johnson shares licence for tuberculosis drug after novelist’s viral campaign

Disease kills millions each year even though it’s curable

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Tylenol linked to autism and ADHD?

The debate over how to interpret acetaminophen science has profound implications for individuals and the public

Salon

Seven murders by cyanide-laced Tylenol will never be solved. But the prime suspect’s death brings justice

After a joint FBI task force was unable to pin the 1982 Tylenol murders on prime suspect James Lewis, special agent Roy Lane was coaxed out of retirement to carry out a daring undercover mission. He tells Bevan Hurley Lewis’ death this week ‘puts the pursuit of justice to an…

The Independent UK

James Lewis, prime suspect in Tylenol tampering cases, dead at 76

James Lewis was found unresponsive at his residence in Cambridge, Mass. His death was determined to be not suspicious, police said.

Chicago Sun-Times

Seven Of The Top 10 Most-Valuable Stocks Are Still Cheap, Analysts Say

Think you missed your chance to profit on the S&P 500's most valuable stocks? Good news: analysts say there's still upside for most of them.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Fortune 500 companies and CEOs react to end of affirmative action

Fortune 500 companies, including Salesforce and Microsoft, reacted to the Supreme Court's decision to reject affirmative action at U.S. colleges and universities.

Fortune

‘People are like, Wow!’: the man trying to make condoms sexy

The long read: It has been said that condoms share marketing characteristics with napalm and funerals. But it is Ben Wilson’s mission to make us believe they are key to human happiness

The Guardian - UK

Chart of the Day: Is Johnson & Johnson Poised for a Breakout?

The Chart of the Day belongs to the healthcare company Johnson & Johnson (JNJ) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the...

Barchart

Opioid settlement payouts made public

Opioid settlement funds have been doled out. In some cases, it's not clear how they're being spent

Salon

Opioid settlement payouts are now public — and we know how much local governments got

KFF Health News obtained documents showing the exact dollar amounts — down to the cent — that local governments have been paid in 2022 and 2023 in lawsuit settlements from the opioid crisis.

WEKU

Future Fortune 500 CEOs: 11 up-and-comers that leadership experts see as generational standout bosses

Fortune has identified 11 CEO stars in the making—many of them already in the C-suite, and all potential large-company CEOs.

Fortune

Ex-chief judge seeks best deal for pelvic mesh victims

"It was impossible not to be affected by the poignant stories told."

Newcastle Herald

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Johnson & Johnson (JNJ) and SNDL Inc. (SNDL) -- Buy or Sell?

Investing in healthcare stocks could help hedge against economic downturns. Thus, Johnson & Johnson (JNJ) could be worth buying. However, I think SNDL (SNDL) is best avoided considering its weak fundamentals. Read on.

Investors Business Daily

Short Sellers Won't Bet Against Eight Rock-Solid Buffett-Like Stocks

Short sellers aren't afraid of many stocks in the S&P 500. But one stock they won't touch is Warren Buffett's Berkshire Hathaway.

Investors Business Daily

Protagonist, A Top 1% Biotech, Briefly Breaks Out On Psoriasis Enthusiasm

Shares of PTGX stock briefly broke out Friday after Protagonist said it plans to soon present new test results for its psoriasis drug.

Kiplinger

Johnson & Johnson Spins Off Kenvue in Biggest IPO Haul Since 2021

Johnson & Johnson rips off Band-Aid and spits out Listerine in a bid to boost margins.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

2 Remaining AAA-Rated Companies Shine As U.S. Gets Downgraded

Lawmakers are playing chicken with the debt ceiling. Luckily there are still two U.S. S&P 500 companies left with AAA credit ratings.

Barchart

The Fed Is About To Raise Rates! Get Ready To Plan Your Next Move!

Here Are 2 Ideas Depending on How the Next Fed Announcement Goes.

The Texas Tribune

Attorney General Ken Paxton to investigate COVID-19 vaccine makers

Long an opponent of vaccine and mask mandates, the Republican said pharmaceutical companies may have misrepresented data. Pfizer strongly disagrees.

The Street

Jim Cramer Recommends That Investors Hold Tight to One Health Care Stock

The CNBC host defends a company whose stock is down.

ABC News

Woodside boss blasts 'extremists' with 'deep pockets' for stopping gas projects, ASX flat, Star sacks 500 workers

Woodside Energy boss Meg O'Neill has used a speech at the National Press Club to criticise extremists for stopping gas projects, while the Australian share market trades flat after a lacklustre session on Wall Street overnight.

Barchart

Markets Today: Stock Index Futures Climb as China’s Economy Strengthens

Morning Markets June S&P 500 futures (ESM2 3) this morning are up +0.49% at a 2-month high, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.79% at a 2-week high. U.S. stock index futures this morning are moderately higher on improved global economic prospects after today’s news that...

Investors Business Daily

These 10 Crummy Stocks Already Cost Investors $300 Billion

What's worse than missing out on the five stocks driving the entire S&P 500 this year? Owning the ones that are dragging it down.

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.